Alcohol Use Disorder Treatment Market Size & Share, by Disorder Type (Alcohol Abuse, Alcohol Dependence, Alcohol Addiction, Alcoholism); Treatment Type (Medication, Therapy, Multidisciplinary Treatment) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3804
  • Published Date: Jan 03, 2023
  • Report Format: PDF, PPT

Companies Dominating the Alcohol Use Disorder Treatment Market

    • Alkermes
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Teva Pharmaceutical Industries Ltd.
    •  BioCorRx, Inc.
    • Adial Pharmaceuticals
    • Kinnov Therapeutics
    • Indivior PLC 
    • Ethypharm 
    • Omeros Corporation

Browse Key Market Insights with Data Illustration:


In The News

  • June 2021- Alkermes plc announced that at the 2021 Research Society on Alcoholism (RSA) Scientific Meeting/International Society for Biomedical Research on Alcoholism (ISBRA) Conference, which was virtually held June 19–23, 2021, new health economics and outcomes research about healthcare resource use (HRU) among veterans with alcohol dependence was presented.
  • August 2024- BioCorRx Inc. declared that it has submitted an extended access program application for BICX104 (implantable naltrexone pellet) to the US Food and Drug Administration (FDA) for the treatment of patients with opioid use disorder (OUD) who satisfy program eligibility requirements.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3804
  • Published Date: Jan 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Awareness among the population regarding advancement in treatment, supportive government policies, increased healthcare expenditure are some of the major market drivers.

The market size of alcohol use disorder treatment is anticipated to attain a CAGR of 6.5 % over the forecast period, i.e., 2024 – 2036.

The major players in the market are Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, Kinnov Therapeutics, ADDEX THERAPEUTICS, Indivior PLC, Ethypharm, Omeros Corporation, Montisera Ltd./ FINNISH BIOINDUSTRIES FIB, Otsuka Pharmaceutical Co., Ltd., and others.

The Multidisciplinary treatment segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying